All In MedTech

FDA Clearance Tracker · P990065-S014

SIR-Spheres Y-90 resin microspheres

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jul 1, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jul 1, 2025

Approved

Time to decision

532 days

Received Jan 16, 2024. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P990065-S014
Device name
SIR-Spheres Y-90 resin microspheres
Applicant location
Woburn, MA
Received
Jan 16, 2024
Decided
Jul 1, 2025
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P990065

Device type

Device class
Class III

Every decision under product code NAW

FDA's approval statement

As written in FDA's record.

SIR-Spheres® Y-90 resin microspheres are indicated for the local tumor control of unresectable hepatocellular carcinoma (HCC) in patients with no macrovascular invasion, Child Pugh-A cirrhosis, well-compensated liver function, and good performance status. They are also indicated for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intrahepatic artery chemotherapy (IHAC) of FUDR (Floxuridine).

Source documents

Other decisions for Sirtex Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.